Stock APPAD HERON THERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Heron Therapeutics Inc OTC Bulletin Board

Equities

APPAD

US4277461020

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Heron Therapeutics Announces the Inclusion of ZYNRELEF as a Qualifying Product under the Proposed 2025 Non-Opioid Policy for Pain Relief under the OPPS and the ASC Payment System
AQ
Heron Therapeutics Says Non-Opioid Pain Medication to be Included in Proposed Medicare Programs
MT
Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System
PR
Heron Therapeutics, Inc. Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System
CI
Heron Reports Acceptance of Prior Approval Supplement Application for Zynrelef Vial Access Needle
MT
Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")
PR
Heron Therapeutics, Inc. Announces Acceptance of the Prior Approval Supplement Application for Zynrelef® Vial Access Needle
CI
Heron Therapeutics, Inc.(NasdaqCM:HRTX) added to S&P Biotechnology Select Industry Index
CI
Connect Biopharma Names New Chief Executive, Chair
MT
Heron Therapeutics Submits Prior Approval Supplement to the FDA for Zynrelef Vial Access Needle
MT
Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")
PR
Heron Therapeutics, Inc. Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")
CI
Heron Therapeutics : Investor Day Presentation
PU
Transcript : Heron Therapeutics, Inc. - Analyst/Investor Day
Transcript : Heron Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024
Heron Therapeutics: Q1 Earnings Snapshot
AQ
Heron Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Heron Therapeutics, Inc. Re-Affirms Earnings Guidance for the Full Year 2024
CI
Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates
PR
Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HRTX Stock
  4. APPAD Stock
  5. News Heron Therapeutics Inc